Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Oncology
|
January 11, 2001
Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
X Pivot, L Cals, D Cupissol, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2004
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer
E Guardiola, F Peyrade, L Chaigneau, et al.
Bulletin Du Cancer
|
August 18, 2018
[Reprint of: Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]
B Guillot, J Charles, G Jeudy, et al.
Annales De Dermatologie Et De Venereologie
|
April 29, 2018
[Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]
B Guillot, J Charles, G Jeudy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 15, 2014
A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
T Y Seiwert, J Fayette, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer
X Pivot, A Awada, D Gedouin, et al.
Lancet (London, England)
|
July 8, 1998
Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma
J J Grob, B Dreno, P de la Salmonière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
A Patrikidou, S Chabaud, I Ray-Coquard, et al.
Annales De Dermatologie Et De Venereologie
|
March 9, 2006
[Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations]
S Négrier, P Saiag, B Guillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Oncology
|
January 11, 2001
Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
X Pivot, L Cals, D Cupissol, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 3, 2004
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer
E Guardiola, F Peyrade, L Chaigneau, et al.
Bulletin Du Cancer
|
August 18, 2018
[Reprint of: Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]
B Guillot, J Charles, G Jeudy, et al.
Annales De Dermatologie Et De Venereologie
|
April 29, 2018
[Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]
B Guillot, J Charles, G Jeudy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 15, 2014
A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
T Y Seiwert, J Fayette, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer
X Pivot, A Awada, D Gedouin, et al.
Lancet (London, England)
|
July 8, 1998
Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma
J J Grob, B Dreno, P de la Salmonière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
A Patrikidou, S Chabaud, I Ray-Coquard, et al.
Annales De Dermatologie Et De Venereologie
|
March 9, 2006
[Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations]
S Négrier, P Saiag, B Guillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Page
of 8